ATE285212T1 - Absorptionsförderer für topische pharmazeutische formulierungen - Google Patents

Absorptionsförderer für topische pharmazeutische formulierungen

Info

Publication number
ATE285212T1
ATE285212T1 AT94930744T AT94930744T ATE285212T1 AT E285212 T1 ATE285212 T1 AT E285212T1 AT 94930744 T AT94930744 T AT 94930744T AT 94930744 T AT94930744 T AT 94930744T AT E285212 T1 ATE285212 T1 AT E285212T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
topical pharmaceutical
absorption promoters
enhancers
dimethylamino
Prior art date
Application number
AT94930744T
Other languages
English (en)
Inventor
Servet Bueyuektimkin
Nadir Bueyuektimkin
Joseph Howard Rytting
Original Assignee
Odontex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Odontex Inc filed Critical Odontex Inc
Application granted granted Critical
Publication of ATE285212T1 publication Critical patent/ATE285212T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94930744T 1993-10-07 1994-10-07 Absorptionsförderer für topische pharmazeutische formulierungen ATE285212T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13345493A 1993-10-07 1993-10-07
PCT/US1994/011597 WO1995009590A1 (en) 1993-10-07 1994-10-07 Absorption enhancers for topical pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE285212T1 true ATE285212T1 (de) 2005-01-15

Family

ID=22458697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94930744T ATE285212T1 (de) 1993-10-07 1994-10-07 Absorptionsförderer für topische pharmazeutische formulierungen

Country Status (10)

Country Link
EP (1) EP0746294B1 (de)
CN (1) CN1133465C (de)
AT (1) ATE285212T1 (de)
AU (1) AU7977294A (de)
CA (1) CA2178594C (de)
DE (1) DE69434199T2 (de)
ES (1) ES2233933T3 (de)
PT (1) PT746294E (de)
RU (1) RU2165265C2 (de)
WO (1) WO1995009590A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295797B6 (cs) * 1997-04-04 2005-11-16 Bochemie, S.R.O. Sloučeniny na bázi derivátů omega-aminokyselin, způsob jejich výroby a jejich použití
CZ2004316A3 (cs) * 2001-09-04 2004-10-13 Trommsdorffágmbhá@Áco@Ákgáarzneimittel Náplast
RU2314795C2 (ru) * 2003-01-20 2008-01-20 ООО Аптека "Реагент" Ушные трубочки
EP2106805B1 (de) * 2003-03-21 2011-06-15 Nexmed Holdings, Inc. Antimykotischer Nagellack und Verfahren zu seiner Verwendung
AU2004227853A1 (en) 2003-04-02 2004-10-21 Nexmed (Holdings), Inc. Prostaglandin compositions and their use for the treatment of vasospasm
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
EP2295036A2 (de) 2004-12-10 2011-03-16 Talima Therapeutics, Inc. Flüssige Zusammensetzungen und Verfahren zur Behandlung von Nagelstörungen
EP2253326B1 (de) * 2008-02-28 2018-04-04 Toray Industries, Inc. Pharmazeutische zusammensetzung zur transnasalen verabreichung
MX2011000009A (es) * 2008-07-10 2011-08-15 Esbatech Alcon Biomed Res Unit Metodos y composiciones para la administracion mejorada de macromoleculas.
WO2010065936A1 (en) * 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
WO2012139033A1 (en) 2011-04-07 2012-10-11 Nexmed Holdings, Inc. Methods and compositions for treating raynaud's disease
DE102013004199A1 (de) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische Zusammensetzung
CA2904703A1 (en) 2013-03-14 2014-10-02 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
US4732892A (en) * 1985-07-12 1988-03-22 American Home Products Corporation L-α-amino acids as transdermal penetration enhancers
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
US4980378A (en) * 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
CA2106483A1 (en) * 1991-03-19 1992-09-20 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers

Also Published As

Publication number Publication date
RU2165265C2 (ru) 2001-04-20
CN1133465C (zh) 2004-01-07
DE69434199D1 (de) 2005-01-27
AU7977294A (en) 1995-05-01
CN1140983A (zh) 1997-01-22
EP0746294B1 (de) 2004-12-22
PT746294E (pt) 2005-03-31
CA2178594A1 (en) 1995-04-13
CA2178594C (en) 2008-12-23
WO1995009590A1 (en) 1995-04-13
EP0746294A1 (de) 1996-12-11
ES2233933T3 (es) 2005-06-16
EP0746294A4 (de) 1998-04-22
DE69434199T2 (de) 2005-12-29

Similar Documents

Publication Publication Date Title
ATE285212T1 (de) Absorptionsförderer für topische pharmazeutische formulierungen
FI924392A0 (fi) Blandning innehaollande farmaceutiskt felbinat.
DE69229098D1 (de) Hochdosierte topische Kollagenaseformen
PT1178833E (pt) Composicoes topicas para administracao de prostaglandina e1
LV11279A (lv) Farmaceitiska kompozicija kas satur nervu augsanas faktoru
DE69330388D1 (de) Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
ES2075011T3 (es) Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
DE69332350D1 (de) Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen
MX9301053A (es) Guanidinas [(benzodioxan, benzofuran o benzopiran)-alquilamino]-alquil-substituidas.
BR9403783A (pt) Uso de uma composição cosmética
ATE94765T1 (de) Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen.
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
NO934107D0 (no) Penetrasjonsfremmende substans
BR9808215A (pt) Preparados de adesivos para lacas, sua preparação e emprego
ES2078256T3 (es) Formula farmaceutica para uso topico que contiene diclofenaco sodico.
DE3776111D1 (de) Pharmazeutische zubereitungen.
DE3881254D1 (de) Pharmazeutische zusammensetzung.
ES2174176T3 (es) Procedimiento para reducir el daño en tejido asociado con la isquemia.
IT1251615B (it) Medicamento ad attivita' antielastasica.
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
TR199701463T1 (en) Sorbin asiti i�eren hidrojel.
IT8848562A0 (it) Preparazioni farmaceutiche per uso topico a base di eparina, eparinoidi e frazioni, lnw eparina e vlmweparina dotate di elevato assorbimento transdermico per la presenza di esteri di colina
MX9205702A (es) Composicion que comprende un material de tramadol y acetaminofen y su uso.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0746294

Country of ref document: EP